PLAGL1 gene related symptoms and diseases

All the information presented here about the PLAGL1 gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: HGNC,NCBIGENE,OMIM,ORPHANET, Mendelian Rare Disease Search Engine.

Top 5 symptoms and clinical features associated to PLAGL1 gene

Symptoms // Phenotype % Cases
Intrauterine growth retardation Very Common - Between 80% and 100% cases
Dehydration Very Common - Between 80% and 100% cases
Macroglossia Common - Between 50% and 80% cases
Transient neonatal diabetes mellitus Common - Between 50% and 80% cases
Generalized myoclonic seizures Common - Between 50% and 80% cases

Other less frequent symptoms and clinical features

Patients with PLAGL1 gene alterations may also develop some of the following symptoms and phenotypes:
  • Commonly - More than 50% cases

  • Diabetes mellitus
  • Hyperglycemia
  • Failure to thrive
  • Not very common - Between 30% and 50% cases

  • Abdominal wall defect
  • Umbilical hernia
  • Glucose intolerance
  • Severe intrauterine growth retardation
  • Severe failure to thrive

And 60 more phenotypes, you can get all of them using our tools for rare diseases.

Rare diseases associated to PLAGL1 gene

Here you will find a list of rare diseases related to the PLAGL1. You can also use our tool to get a more accurate diagnosis based on your current symptoms.


TRANSIENT NEONATAL DIABETES MELLITUS

Alternate names

TRANSIENT NEONATAL DIABETES MELLITUS Is also known as tndm3, tndm

Description

Transient neonatal diabetes mellitus (TNDM) is a genetically heterogeneous form of neonatal diabetes (NDM, see this term) characterized by hyperglycemia presenting in the neonatal period that remits during infancy but recurs in later life in most patients.

Most common symptoms of TRANSIENT NEONATAL DIABETES MELLITUS

  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Hearing impairment
  • Failure to thrive


More info about TRANSIENT NEONATAL DIABETES MELLITUS

SOURCES: ORPHANET OMIM

DIABETES MELLITUS, TRANSIENT NEONATAL, 1

Alternate names

DIABETES MELLITUS, TRANSIENT NEONATAL, 1 Is also known as tndm1, dmtn, tndm

Description

Neonatal diabetes mellitus (NDM), defined as insulin-requiring hyperglycemia within the first month of life, is a rare entity, with an estimated incidence of 1 in 400,000 neonates (Shield, 2000). In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes (OMIM ). In a significant number of patients with transient neonatal diabetes mellitus, type II diabetes appears later in life (Arthur et al., 1997).The major cause of transient neonatal diabetes (TND) is aberrant expression of imprinted genes at chromosome 6q24, associated in 20% of cases with DNA hypomethylation at the TND differentially methylated region (DMR), which lies within the imprinted promoter of the PLAGL1 gene ({603044}; Mackay et al., 2005). Over 50% of individuals with TND and hypomethylation at 6q24 also show mosaic DNA hypomethylation at other imprinted loci throughout the genome and a range of additional clinical features. Genetic Heterogeneity of Transient Neonatal DiabetesTNDM2 (OMIM ) is caused by mutation in the ABCC8 gene (OMIM ) on chromosome 11p15.1. TNDM3 (OMIM ) is caused by mutation in the KCNJ11 gene (OMIM ), also located on 11p15.1.

Most common symptoms of DIABETES MELLITUS, TRANSIENT NEONATAL, 1

  • Growth delay
  • Hypertelorism
  • Failure to thrive
  • Intrauterine growth retardation
  • Talipes equinovarus


More info about DIABETES MELLITUS, TRANSIENT NEONATAL, 1

SOURCES: OMIM

PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6

Alternate names

PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6 Is also known as upd(6)pat

Description

Paternal uniparental disomy of chromosome 6 is an uniparental disomy of paternal origin characterized by intrauterine growth retardation, transient neonatal diabetes mellitus, and macroglossia.

Most common symptoms of PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6

  • Micrognathia
  • Cryptorchidism
  • High palate
  • Hepatomegaly
  • Intrauterine growth retardation


More info about PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6

SOURCES: ORPHANET


Potential gene panels for PLAGL1 gene

6q24 MS-MLPA for transient neonatal diabetes Panel

United States.

By Genetic Services Laboratory University of Chicago 6q24 MS-MLPA for transient neonatal diabetes that also includes the following genes: HYMAI PLAGL1

More info about this panel
United States.

Comprehensive Neonatal Diabetes Mutation Analysis Panel

United States.

By Genetic Services Laboratory University of Chicago Comprehensive Neonatal Diabetes Mutation Analysis that also includes the following genes: ZFP57 EIF2AK3 GATA4 GATA6 GCK MNX1 HYMAI ABCC8 INS FOXP3

More info about this panel
United States.

Test for Diabetes Mellitus, 6q24-Related Transient Neonatal Panel

Germany.

By MGZ Medical Genetics Center

This panel specifically test the PLAGL1 gene.

More info about this panel
Germany.

Uniparental Disomy of Chromosome 6 Panel

United States.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics Uniparental Disomy of Chromosome 6 that also includes the following genes: HYMAI PLAGL1

More info about this panel
United States.

Transient Neonatal Diabetes Mellitus NGS Panel Panel

United States.

By Fulgent Genetics Fulgent Genetics Transient Neonatal Diabetes Mellitus NGS Panel that also includes the following genes: HYMAI PLAGL1

More info about this panel
United States.

PLAGL1 Panel

United States.

By Fulgent Genetics Fulgent Genetics

This panel specifically test the PLAGL1 gene.

More info about this panel
United States.

Tempus xO assay Panel

United States.

By Tempus Labs, Inc. Tempus xO assay that also includes the following genes: BCL6 RHEB RIPK1 RIPK2 RIPK3 RIT1 BCL7A BCL9 BCR ROBO2

More info about this panel
United States.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like LIPA ROBO1 PIGT AKR1D1 CYP2B6 RSPH4A PI4KA